Septal reduction therapy in obstructive hypertrophic cardiomyopathy: contextualizing outcomes in an era of cardiac myosin inhibition
European Heart Journal Open · 18.05.2026 · 6 (3)
DOI: 10.1093/ehjopen/oeag087 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Heart Journal Open, online erschienen am 22.05.2026. Verfasst von Anirudh Govind. Beteiligte Einrichtung: Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Dhanvantri Nagar, Pondicherry 605006, India. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Dhanvantri Nagar, Pondicherry 605006, India.
ORCID-Profile: Anirudh Govind
Zitieren
APA
Govind, A. (2026). Septal reduction therapy in obstructive hypertrophic cardiomyopathy: contextualizing outcomes in an era of cardiac myosin inhibition. European Heart Journal Open, 6(3). https://doi.org/10.1093/ehjopen/oeag087
Vancouver
Govind A. Septal reduction therapy in obstructive hypertrophic cardiomyopathy: contextualizing outcomes in an era of cardiac myosin inhibition. European Heart Journal Open. 2026;6(3). doi:10.1093/ehjopen/oeag087
BibTeX
@article{Govind2026,
author = {Govind, Anirudh},
title = {Septal reduction therapy in obstructive hypertrophic cardiomyopathy: contextualizing outcomes in an era of cardiac myosin inhibition},
journal = {European Heart Journal Open},
year = {2026},
volume = {6},
number = {3},
doi = {10.1093/ehjopen/oeag087}
}
EUVIMED